These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6765222)

  • 1. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII.
    Home PD; Capaldo B; Burrin JM; Worth R; Alberti KG
    Diabetes Care; 1982; 5(5):466-71. PubMed ID: 6765222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions.
    Marshall SM; Home PD; Taylor R; Alberti KG
    Diabet Med; 1987; 4(6):521-5. PubMed ID: 2962807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas.
    Jennings AM; Lewis KS; Murdoch S; Talbot JF; Bradley C; Ward JD
    Diabetes Care; 1991 Aug; 14(8):738-44. PubMed ID: 1954811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.
    Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM
    Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations.
    Rodger NW; Dupre J; Canny CL; Brown WF
    Diabetes Care; 1985; 8(5):447-55. PubMed ID: 3902423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial.
    de Beaufort CE; Houtzagers CM; Bruining GJ; Aarsen RS; den Boer NC; Grose WF; van Strik R; de Visser JJ
    Diabet Med; 1989 Dec; 6(9):766-71. PubMed ID: 2533034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nocturnal continuous subcutaneous insulin infusion--a therapeutic possibility in labile type I diabetes under exceptional conditions].
    Bruns W; Steinborn F; Menzel R; Staritz B; Bibergeil H
    Z Gesamte Inn Med; 1990 Mar; 45(6):154-8. PubMed ID: 2197828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
    Pickup J; Keen H
    Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
    Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
    Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen.
    Saurbrey N; Arnold-Larsen S; Møller-Jensen B; Kühl C
    Diabet Med; 1988 Mar; 5(2):150-3. PubMed ID: 2964981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous insulin infusion therapy and retinopathy in patients with type I diabetes.
    Helve E; Laatikainen L; Merenmies L; Koivisto VA
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):313-9. PubMed ID: 3303785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective.
    St Charles M; Lynch P; Graham C; Minshall ME
    Value Health; 2009; 12(5):674-86. PubMed ID: 19171006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of unstable type I diabetes: conventional versus portable pump insulin administration.
    Cavallo-Perin P; Pagano G; Tagliaferro V; Jarre P; Ozzello A; Lenti G
    Acta Diabetol Lat; 1983; 20(4):363-70. PubMed ID: 6364666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections.
    Schiffrin A; Belmonte M
    Diabetes Care; 1982; 5(5):479-84. PubMed ID: 6765224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.